Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A new tumorgraft panel to accelerate precision medicine in prostate cancer. | Front Oncol | 2023 | 37305585 | PubTator, text mining | PubMed |
| Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype. | Int J Mol Sci | 2023 | 37298233 | PubTator, text mining | PubMed |
| Regulation of PD-L1 Trafficking from Synthesis to Degradation. | Cancer Immunol Res | 2023 | 37290119 | PubTator, text mining | PubMed |
| Clinical significance of SPOP and APC gene alterations in colorectal cancer in Indian population. | Mol Genet Genomics | 2023 | 37289229 | PubTator, text mining | PubMed |
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors. | Clin Cancer Res | 2023 | 37289194 | PubTator, text mining | PubMed |
| The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer. | Cancer Res | 2023 | 37289025 | PubTator, text mining | PubMed |
| Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer. | Epigenetics | 2023 | 37279148 | PubTator, text mining | PubMed |
| Aspartoacylase suppresses prostate cancer progression by blocking LYN activation. | Mil Med Res | 2023 | 37271807 | PubTator, text mining | PubMed |
| Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence. | BMC Cancer | 2023 | 37254049 | PubTator, text mining | PubMed |
| MicroRNA-372 acts as a double-edged sword in human cancers. | Heliyon | 2023 | 37251909 | PubTator, text mining | PubMed |
| Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses. | Front Immunol | 2023 | 37251408 | PubTator, text mining | PubMed |
| Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 37240349 | PubTator, text mining | PubMed |
| Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer. | Int J Mol Sci | 2023 | 37240308 | PubTator, text mining | PubMed |
| Prognostic Values of Gene Copy Number Alterations in Prostate Cancer. | Genes (Basel) | 2023 | 37239316 | PubTator, text mining | PubMed |
| Recent advances in understanding DNA methylation of prostate cancer. | Front Oncol | 2023 | 37234978 | PubTator, text mining | PubMed |
| CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer. | Oncogenesis | 2023 | 37230983 | PubTator, text mining | PubMed |
| Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate cancer: a case report. | J Immunother Cancer | 2023 | 37220954 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy. | Front Immunol | 2023 | 37215134 | PubTator, text mining | PubMed |
| Molecular evolution of Keap1 was essential for adaptation of vertebrates to terrestrial life. | Sci Adv | 2023 | 37205751 | PubTator, text mining | PubMed |
| Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer. | Front Oncol | 2023 | 37205181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=20